Abstract
Purpose: To investigate the correlation between conductivity and prognostic factors of invasive breast cancer using magnetic resonance electric properties tomography (MREPT). Methods: This retrospective study was approved by the Institutional Review Board, and verbal informed consent was obtained prior to breast MRI. This study included 65 women with surgically confirmed invasive breast cancers measuring 1 cm or larger on T2-weighted fast spin echo (FSE). Phase-based MREPT and the coil combination technique were used to reconstruct conductivity. Simple and multiple linear regression analysis were used to find an independent factor associated with conductivity. Results: In total tumours, tumours with HER-2 overexpression showed lower conductivity than those without, and HER-2 overexpression was independently associated with conductivity. In 37 tumours 2 cm or larger, tumours with high mitosis or PR positivity showed higher conductivity than those without, and high mitosis and PR positivity were independently associated with conductivity. In 28 tumours 1–2 cm in size, there were no differences in conductivity according to the prognostic factors. Conclusion: Conductivity values measured using MREPT are associated with the HER-2 overexpression status, and may provide information about mitosis and the PR status of invasive breast cancers 2 cm or larger. Key Points: • In all tumours, HER-2 overexpression was independently associated with conductivity. • In tumours ≥ 2 cm, high mitosis and PR positivity were associated with conductivity. • Conductivity is associated with the HER-2 overexpression status of invasive breast cancers.
| Original language | English |
|---|---|
| Pages (from-to) | 2317-2326 |
| Number of pages | 10 |
| Journal | European Radiology |
| Volume | 26 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 2016 Jul 1 |
Bibliographical note
Funding Information:The scientific guarantor of this publication is Eun-Kyung Kim. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. This study was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (grant 2013R1A1A3013165). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We thank Ha Yan Kim, statistician of the Biostatistics Collaboration Unit, Medical Research Center, Yonsei University, College of Medicine, Seoul, Korea for her help with the statistical analysis. Institutional Review Board approval was obtained. Written informed consent was waived by the Institutional Review Board. Verbal informed consents were obtained from all patients prior to breast MRI. Some study subjects or cohorts have not been previously reported. Methodology: prospective, diagnostic or prognostic study, performed at one institution.
Publisher Copyright:
© 2015, European Society of Radiology.
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging
